Asymmetric activation of the calcium-sensing receptor homodimer

Yang Gao,Michael J. Robertson,Sabrina N. Rahman,Alpay B. Seven,Chensong Zhang,Justin G. Meyerowitz,Ouliana Panova,Fadil M. Hannan,Rajesh V. Thakker,Hans Bräuner-Osborne,Jesper M. Mathiesen,Georgios Skiniotis
DOI: https://doi.org/10.1038/s41586-021-03691-0
IF: 64.8
2021-06-30
Nature
Abstract:The calcium-sensing receptor (CaSR), a cell-surface sensor for Ca<sup>2+</sup>, is the master regulator of calcium homeostasis in humans and is the target of calcimimetic drugs for the treatment of parathyroid disorders<sup><a href="/articles/s41586-021-03691-0#ref-CR1">1</a></sup>. CaSR is a family C G-protein-coupled receptor<sup><a href="/articles/s41586-021-03691-0#ref-CR2">2</a></sup> that functions as an obligate homodimer, with each protomer composed of a Ca<sup>2+</sup>-binding extracellular domain and a seven-transmembrane-helix domain (7TM) that activates heterotrimeric G proteins. Here we present cryo-electron microscopy structures of near-full-length human CaSR in inactive or active states bound to Ca<sup>2+</sup> and various calcilytic or calcimimetic drug molecules. We show that, upon activation, the CaSR homodimer adopts an asymmetric 7TM configuration that primes one protomer for G-protein coupling. This asymmetry is stabilized by 7TM-targeting calcimimetic drugs adopting distinctly different poses in the two protomers, whereas the binding of a calcilytic drug locks CaSR 7TMs in an inactive symmetric configuration. These results provide a detailed structural framework for CaSR activation and the rational design of therapeutics targeting this receptor.
multidisciplinary sciences
What problem does this paper attempt to address?